Amendment to Reclassify Hydrocodone as Schedule II Controlled Substance Passes US Senate

Topics: Controlled substances and Federal regulations

Aimed to help combat prescription drug abuse, an amendment to the FDA Safety and Innovation Act that would reclassify hydrocodone as a Schedule II controlled substance passed in the US senate on May 24, 2012. If adopted as law, “patients would need an original prescription for refills, pills would be stored and transported more securely, and traffickers would be subject to increased fines and penalties,” as explained in a statement by one of the bill’s sponsors, US Senator Joe Manchin (D-WV). The amendment was cosponsored by Senators Mark Kirk (R-IL), Kirsten Gillibrand (D-NY), Chuck Schumer (D-NY), and Jay Rockefeller (D-WV). The FDA Safety and Innovation Act (S 3187) as passed by the US Senate, is now with the US House of Representatives.